A “structured dialog” with pharmaceutical industry stakeholders that has been initiated by the European Commission offers an opportunity to bolster the environment for local manufacturing and address weaknesses in the stability and security of the supply chain, according to local off-patent industry association Medicines for Europe.
The move represents an initial step to implement the EU Pharma Strategy that was set out in November last year....





